Product Information
FOCALIN XR 5 MG CAPSULE is a brand product labeled by Sandoz Inc., priced at $4.7035 per EA under NDC 66758023501. Its NADAC has been published 83 times since Mar 5, 2025.
FDA first approved this application on May 26, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the dexmethylphenidate hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Sandoz Inc.NDC
66758023501
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021802FDA Approved
5/26/2005
TE Code
AB
On Market Since
5/31/2005
Pharmacological Classes
Price Statistics
The NADAC for FOCALIN XR 5 MG CAPSULE has been published 83 times since Mar 5, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.7035 per EA |
|---|---|
| All-time high | $4.7321 (Mar 11, 2026) |
| All-time low | $4.6971 (May 20, 2026) |
| 52-week high | $4.7321 |
| 52-week low | $4.6971 |
| Median price | $4.7104 |
| Average price | $4.7117 |
| Largest weekly change | +0.5% (Nov 19, 2025) |
| Weeks tracked | 83 |
| Tracking since | Mar 5, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 78% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dexmethylphenidate hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FOCALIN XR 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FOCALIN XR 5 MG CAPSULE, manufactured by Sandoz Inc., is $4.7035 per EA (NDC 66758023501), effective Sep 30, 2026.
How has the price of FOCALIN XR 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FOCALIN XR 5 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 83 weekly CMS publications since Mar 5, 2025.
What are the highest and lowest recorded NADAC prices for FOCALIN XR 5 MG CAPSULE?
Since Mar 5, 2025, the NADAC for FOCALIN XR 5 MG CAPSULE has ranged from a low of $4.6971 (May 20, 2026) to a high of $4.7321 (Mar 11, 2026), with a median of $4.7104 per EA.
Are there cheaper alternatives to FOCALIN XR 5 MG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXMETHYLPHENIDATE ER 5 MG CAP, is $1.0137 per EA — about 78% below FOCALIN XR 5 MG CAPSULE.
Who manufactures FOCALIN XR 5 MG CAPSULE?
FOCALIN XR 5 MG CAPSULE (NDC 66758023501) is labeled by Sandoz Inc., and CMS classifies it as a brand product.